129 related articles for article (PubMed ID: 24503796)
1. Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer.
Tuna M; Itamochi H
Tumori; 2013; 99(6):715-22. PubMed ID: 24503796
[TBL] [Abstract][Full Text] [Related]
2. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer.
Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P
Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380
[TBL] [Abstract][Full Text] [Related]
4. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers.
Keating GL; Reid HM; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta; 2014 Jun; 1839(6):476-92. PubMed ID: 24747176
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
Jomgeow T; Oji Y; Tsuji N; Ikeda Y; Ito K; Tsuda A; Nakazawa T; Tatsumi N; Sakaguchi N; Takashima S; Shirakata T; Nishida S; Hosen N; Kawakami M; Tsuboi A; Oka Y; Itoh K; Sugiyama H
Cancer Sci; 2006 Apr; 97(4):259-70. PubMed ID: 16630117
[TBL] [Abstract][Full Text] [Related]
7. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
9. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
Sarfstein R; Werner H
J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
[TBL] [Abstract][Full Text] [Related]
10. The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance.
Wang L; Zhang X; Wang ZY
Anticancer Res; 2010 Sep; 30(9):3637-42. PubMed ID: 20944147
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.
Werner H; Shen-Orr Z; Rauscher FJ; Morris JF; Roberts CT; LeRoith D
Mol Cell Biol; 1995 Jul; 15(7):3516-22. PubMed ID: 7791758
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin.
Zhang TF; Yu SQ; Guan LS; Wang ZY
Anticancer Res; 2003; 23(5A):3575-84. PubMed ID: 14666652
[TBL] [Abstract][Full Text] [Related]
13. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
14. Detection of a novel truncated WT1 transcript in human neoplasia.
Dechsukhum C; Ware JL; Ferreira-Gonzalez A; Wilkinson DS; Garrett CT
Mol Diagn; 2000 Jun; 5(2):117-28. PubMed ID: 11066013
[TBL] [Abstract][Full Text] [Related]
15. Analytical validation of a real-time reverse transcription-polymerase chain reaction quantitation of different transcripts of the Wilms' tumor suppressor gene (WT1).
Dumur CI; Dechsukhum C; Wilkinson DS; Garrett CT; Ware JL; Ferreira-Gonzalez A
Anal Biochem; 2002 Oct; 309(1):127-36. PubMed ID: 12381371
[TBL] [Abstract][Full Text] [Related]
16. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells.
Tuna M; Chavez-Reyes A; Tari AM
Oncogene; 2005 Feb; 24(9):1648-52. PubMed ID: 15674342
[TBL] [Abstract][Full Text] [Related]
17. High Wilms' tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer.
Qi XW; Zhang F; Yang XH; Fan LJ; Zhang Y; Liang Y; Ren L; Zhong L; Chen QQ; Zhang KY; Zang WD; Wang LS; Zhang Y; Jiang J
Oncol Rep; 2012 Oct; 28(4):1231-6. PubMed ID: 22797561
[TBL] [Abstract][Full Text] [Related]
18. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
19. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor.
Gupta S; Joshi K; Wig JD; Arora SK
Indian J Cancer; 2009; 46(4):303-10. PubMed ID: 19749460
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
